Amniotext patches are minimally manipulated, amniotic membrane-derived, human tissue allografts. The product serves as wound covering.
INTENDED USES: It is typically used for chronic non-healing wounds such as diabetic foot ulcers and venous leg ulcers.
CLAIMED BENEFITS: It provides the extracellular matrix needed for the infiltration, attachment and proliferation of cells required for repair of damaged tissue.
OPTION: The graft is applied directly to the wound bed and is available in various sizes, the size used matches the wound defect. The product is packaged in a transport protective pouch. The product is contained in a dual package tissue container system, in which the outermost ploy-foil pouch contains a product label that includes the product details such as unique product number, storage requirements and size. Contents are aseptically processed and sterilized, and are considered sterile.
APF2–11: Amniotext Patch, 1x1 cm: Q4247
APF2–22: Amniotext Patch, 2x2 cm: Q4247
APF2–23: Amniotext Patch, 2x3 cm: Q4247
APF2–33: Amniotext Patch, 3x3 cm: Q4247
APF2–34: Amniotext Patch, 3x4 cm: Q4247
APF2–44: Amniotext Patch, 4x4 cm: Q4247
APF2–46: Amniotext Patch, 4x6 cm: Q4247
APF2–48: Amniotext Patch, 4x8 cm: Q4247
APF2–88: Amniotext Patch, 8x8 cm: Q4247
APF2–10: Amniotext Patch, 10x10 cm: Q4247
Manufacturer: Regenative Labs
Information retrieved from manufacturer and/or FDA-approved labels